Gabapentin Ointment

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of gabapentin ointment in China. Welcome to wholesale bulk high quality gabapentin ointment for sale here from our factory. Good service and reasonable price are available.

Gabapentin Ointment (chemical name: 1- (aminomethyl) cyclohexanecarboxylic acid) is a cyclic derivative of gamma aminobutyric acid (GABA). Its cyclic structure endows it with high lipid solubility, making it easy to penetrate the blood-brain barrier and achieve effective concentrations in the central nervous system (CNS). The molecule contains an aminomethyl side chain, which has a chemical structure similar to GABA but does not directly act on GABA receptors. It can treat peripheral neuropathic pain, such as diabetes peripheral neuropathy, PHN, etc. Local application can directly act on the pain site to reduce systemic side effects. It can also affect local neuronal excitability through transdermal absorption, but clinical evidence is insufficient. For pain related to skin diseases, such as acute skin pain in herpes zoster, local administration may accelerate symptom relief. Gabapentin containing hydrogel or liposome gel can partially improve the local efficacy by improving drug solubility and skin retention time. Clinical feedback shows that local application can alleviate pain in PHN patients, but requires frequent administration (2-4 times a day).

Additional information of chemical compound:

Gabapentin  COA

Gabapentin, as a voltage dependent calcium channel α ₂ δ subunit modulator, was initially developed for antiepileptic therapy and later expanded to indications such as neuropathic pain and restless leg syndrome. Its oral preparations often have systemic side effects such as drowsiness and dizziness due to the need to exert central functions through the blood-brain barrier. To reduce systemic exposure and improve local efficacy, the development of Gabapentin Ointment has become a focus. However, the lipid bilayer structure of the stratum corneum as the main barrier significantly limits the transdermal absorption of drugs. In recent years, the theory of "temporary pores" has provided a new perspective for transdermal drug delivery, which involves using specific techniques or penetration enhancers to temporarily disrupt the lipid arrangement in the stratum corneum, forming reversible microchannels to promote drug penetration.

01.

Classic transdermal route

The transdermal absorption of drugs mainly occurs through three pathways:
Intercellular pathway: Drugs bypass keratinocytes and diffuse through intercellular lipids. This pathway has low resistance, but the hydrophobicity of the lipid bilayer limits the penetration of hydrophilic drugs.
Cross cellular pathway: drugs directly penetrate keratinocytes and intercellular matrix. Due to the abundance of keratin microfilaments in keratinocytes, the efficiency of this pathway is extremely low.
Bypass pathway: Drugs enter the skin through hair follicles, sebaceous glands, or sweat glands. Although these appendages only account for 1% of the skin area, they play an important auxiliary role in large molecules or ionic substances.

02.

Gabapentin's Transdermal Challenge

Gabapentin has a molecular weight of 171.24, low lipid solubility (log P ≈ 1.05), and requires a therapeutic concentration (several milligrams per square centimeter for local pain treatment) to be effective. However, the barrier effect of the stratum corneum makes it difficult to achieve effective penetration through passive diffusion. Research has shown that simply adding Gabapentin to the cream base is not sufficient to achieve clinical efficacy in terms of transdermal rate, and penetration enhancement techniques are needed to break through barriers.

Mechanism of action of penetration enhancers

 

Penetrating agents induce "temporary pores" through the following methods:

Disrupting lipid arrangement: Chemical enhancers such as azone and azone can insert into the lipid bilayer, disrupting the tight arrangement of fatty acid chains and forming hydrophobic channels. For example, after treatment with azone, the CH stretching vibration peak of the stratum corneum shifted towards longer wavelengths at 2800-2950 cm ⁻¹, indicating a change in lipid side chain conformation and an increase in disorder.
Extracting lipid components: Organic solvents such as methanol and chloroform can dissolve intercellular lipids and directly expand drug diffusion channels.
Changing the structure of keratinocytes: Fruit acids, salicylic acids, etc. reduce diffusion resistance by peeling off the stratum corneum, but may cause skin irritation.

Synergistic effects of physical infiltration technology

 

Ion introduction method: using an electric field to drive charged drug molecules to penetrate the skin. Research has shown that iontophoresis can increase the transdermal rate of Gabapentin by 3-5 times, especially for ionic drugs.
Microneedle technology: By using micrometer sized needles to form microchannels in the stratum corneum, drugs can directly enter the dermis layer. Animal experiments have shown that after microneedle pretreatment, the local bioavailability of Gabapentin increases by 40%.
Ultrasonic import: Utilizing the cavitation effect generated by low-frequency ultrasound to temporarily loosen the lipid bilayer structure. Preclinical data shows that ultrasound treatment can increase drug penetration by 2-3 times.

Reversibility of "Temporary Pores"

 

The key lies in the transience of the pores: after the cessation of penetration enhancers or physical stimuli, the lipid bilayer can restore its barrier function through self-assembly. For example, after treatment with azone, the lipid phase transition temperature of the stratum corneum returned to baseline levels within 24 hours, indicating reversible structural damage. This characteristic ensures drug penetration efficiency while avoiding skin damage caused by long-term barrier disruption.

Selection and optimization of penetration enhancers

Chemical penetration enhancer: Azone has become a candidate penetration enhancer for Gabapentin Ointment due to its strong and low irritant properties. Research has shown that 1% azone can increase the transdermal rate of Gabapentin from 0.5 μ g/cm ²/h to 2.8 μ g/cm ²/h.
Natural penetration enhancers: Menthol, eucalyptus oil, etc. indirectly enhance drug penetration by dilating blood vessels and nerve endings sensitivity. Although its mechanism is not fully understood, clinical feedback shows that formulations containing menthol can significantly alleviate pain in PHN patients.
Composite infiltration system: Combining chemical and physical infiltration techniques, such as azone+microneedles, can produce synergistic effects. In vitro experiments have shown that the composite system increases the cumulative permeation of Gabapentin by 6 times compared to using a single penetration enhancer.

Innovation in Formulation Process

Nanocarrier technology:
Liposomes: Gabapentin is encapsulated in a phospholipid bilayer, utilizing its similarity to stratum corneum lipids to prolong drug retention time. The rabbit skin experiment showed that the transdermal rate of the liposome drug delivery system was 2.3 times that of ordinary cream.
Solid lipid nanoparticles (SLN): using solid lipids as carriers to improve drug stability. The particle size of SLN (50-200 nm) allows it to penetrate the hair follicle opening and achieve targeted delivery.
Hydrogel matrix: Soften the cuticle through high moisture content, and control drug release at the same time. Polyacrylic acid hydrogel can reduce the release rate of Gabapentin to 0.2 μ g/cm ²/h, which is suitable for long-term analgesia.

Preclinical evaluation and safety

In vitro permeation experiment: Use Franz diffusion cell to evaluate the effect of different penetration enhancers on the transdermal rate of Gabapentin. For example, an ointment containing 5% azone had a cumulative permeation of 12.5 μ g/cm ² within 8 hours, significantly higher than the control group (2.1 μ g/cm ²).
Skin irritation test: Evaluate the safety of the formulation through Draize test. When the concentration of azone exceeds 3%, it may cause mild erythema, so its dosage needs to be optimized.
Pharmacodynamic validation: In the PHN animal model, Gabapentin Ointment (containing 2% azone) can increase the pain threshold by 40%, which is equivalent to oral formulations, but reduces systemic exposure by 80%.

As the largest organ in the human body, the skin's stratum corneum structure forms a natural barrier for drug penetration. The stratum corneum is composed of multiple layers of dead keratinocytes and intercellular lipids, forming a "brick wall structure" that significantly hinders the transdermal absorption of water-soluble, macromolecular, and ionic drugs. Traditional transdermal drug delivery systems (TDDS) often rely on chemical penetration enhancers (CPEs) such as ethanol, propylene glycol, and azone to enhance drug penetration by disrupting the lipid bilayer or extracting lipids from the stratum corneum. However, such methods may cause side effects such as skin irritation and damage to barrier function, limiting their long-term application.

Hot Tags: gabapentin ointment, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale